Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.79B |
| 2 |
Meta Platforms (Facebook)
META
|
+$838M |
| 3 |
TotalEnergies
TTE
|
+$638M |
| 4 |
UnitedHealth
UNH
|
+$477M |
| 5 |
Coca-Cola
KO
|
+$385M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$841M |
| 2 |
TSMC
TSM
|
+$665M |
| 3 |
Philip Morris
PM
|
+$629M |
| 4 |
Citigroup
C
|
+$475M |
| 5 |
Microsoft
MSFT
|
+$475M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.25% |
| 2 | Financials | 12.81% |
| 3 | Healthcare | 10.33% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Huntsman Corp
HUN
$1.81B
| $5.43M | ﹤0.01% |
543,045
-776,125
| -59% | -$7.11M |
|
|
PPTA
2277
Perpetua Resources
PPTA
$3.16B
| $5.42M | ﹤0.01% |
223,898
+19,813
| +10% | +$487K |
|
|
HOUS
2278
DELISTED
Anywhere Real Estate
HOUS
| $5.38M | ﹤0.01% |
379,840
+24,498
| +7% | +$300K |
|
2279
Disc Medicine
IRON
$3.03B
| $5.38M | ﹤0.01% |
67,707
+2,907
| +4% | +$246K |
|
|
SRTA
2280
Strata Critical Medical Inc
SRTA
$522M
| $5.38M | ﹤0.01% |
1,117,803
-95,176
| -8% | -$460K |
|
2281
AtriCure
ATRC
$2.25B
| $5.36M | ﹤0.01% |
135,572
-18,485
| -12% | -$678K |
|
2282
Agios Pharmaceuticals
AGIO
$2B
| $5.36M | ﹤0.01% |
196,893
-73,203
| -27% | -$2.57M |
|
2283
Novavax
NVAX
$1.33B
| $5.35M | ﹤0.01% |
796,319
+307,074
| +63% | +$2.31M |
|
|
SMA
2284
SmartStop Self Storage REIT
SMA
$1.89B
| $5.35M | ﹤0.01% |
172,946
+78,324
| +83% | +$2.65M |
|
2285
Amalgamated Financial
AMAL
$1.53B
| $5.35M | ﹤0.01% |
167,007
+11,131
| +7% | +$324K |
|
2286
The RealReal
REAL
$1.39B
| $5.35M | ﹤0.01% |
338,982
-7,455
| -2% | -$97.3K |
|
2287
Scansource
SCSC
$1.08B
| $5.33M | ﹤0.01% |
136,484
-362
| -0.3% | -$15K |
|
2288
Helix Energy Solutions
HLX
$1.54B
| $5.32M | ﹤0.01% |
848,084
+15,189
| +2% | +$101K |
|
2289
Frontline
FRO
$9.17B
| $5.3M | ﹤0.01% |
243,043
-256,619
| -51% | -$6M |
|
2290
HealthStream
HSTM
$846M
| $5.29M | ﹤0.01% |
229,233
+19,159
| +9% | +$482K |
|
2291
Celldex Therapeutics
CLDX
$3.29B
| $5.28M | ﹤0.01% |
194,552
-11,142
| -5% | -$293K |
|
|
GOLD
2292
Gold.com Inc
GOLD
$1.28B
| $5.28M | ﹤0.01% |
155,061
-48,956
| -24% | -$1.4M |
|
2293
Vanguard Morningstar Small-Cap Growth ETF
VBK
$25B
| $5.28M | ﹤0.01% |
17,474
+1,863
| +12% | +$562K |
|
2294
Ceco Environmental
CECO
$4.66B
| $5.28M | ﹤0.01% |
88,176
-2,759
| -3% | -$148K |
|
|
DCH
2295
Dauch Corp
DCH
$1.6B
| $5.28M | ﹤0.01% |
823,078
+30,549
| +4% | +$190K |
|
2296
Aurinia Pharmaceuticals
AUPH
$2.06B
| $5.25M | ﹤0.01% |
329,353
+15,851
| +5% | +$225K |
|
2297
iShares Dow Jones US ETF
IYY
$3.09B
| $5.25M | ﹤0.01% |
31,664
+2,055
| +7% | +$338K |
|
2298
Array Technologies
ARRY
$778M
| $5.25M | ﹤0.01% |
569,276
-20,814
| -4% | -$179K |
|
|
JBS
2299
JBS N.V.
JBS
$44.9B
| $5.25M | ﹤0.01% |
363,888
+12,374
| +4% | +$170K |
|
2300
Marqeta
MQ
$1.7B
| $5.23M | ﹤0.01% |
275,249
-36,179
| -12% | -$695K |
|
Similar funds
Bank of New York Mellon's Q4 2025 Portfolio in Review
As of Q4 2025, Bank of New York Mellon held 4,340 positions worth $568B, up 1.8% from $557B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Bank of New York Mellon's Q4 2025 filing shows 170 new, 1,819 increased, 2,090 reduced and 159 closed positions. Its largest new stake was Horizon International Managed Risk ETF: 14,143,461 shares worth $363M. The largest sale was Amphenol, an estimated $841M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q4 2025 buy was Horizon International Managed Risk ETF: 14,143,461 shares worth $363M.
- Bank of New York Mellon added most to Vanguard S&P 500 ETF in Q4 2025, an estimated $1.79B increase.
- Bank of New York Mellon's biggest Q4 2025 reduction was Amphenol, cutting an estimated $841M.
- Bank of New York Mellon fully exited Interpublic Group of Companies in Q4 2025, selling an estimated $121M.
- Bank of New York Mellon's ten largest holdings make up 28% of its $568B portfolio in Q4 2025.
- Bank of New York Mellon opened 170 new positions and closed 159 in Q4 2025.
- Bank of New York Mellon's portfolio value rose 1.8% quarter-over-quarter to $568B.
Based on Bank of New York Mellon's 13F filing for Q4 2025, filed 10 Feb 2026.